Skip to Main Content

Paper Details

The "FIFTY SHADOWS" of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease.
J Clin Med
1
2022
Aldactone, CKD, Chronic Kidney Disease, HF, HK, Hyperkalaemia, K, Patients, Potassium, RAASis, aldosterone, angiotensin, arrhythmias, chronic kidney disease, diabetes, electrolyte disorders, glomerular diseases, hypertension, patients, potassium, renin
Author NameAffiliation
Antonio Bellasi
Antonio Bellasi
Claudio RoncoInternational Renal Research Institute of Vicenza
Claudio RoncoDIMED-University of Padova
  • 1 - 4

Datasets

Release 1.2